Literature DB >> 11853888

Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols.

Julie Jodoin1, Michel Demeule, Richard Beliveau.   

Abstract

Many beneficial proprieties have been associated with polyphenols from green tea, such as chemopreventive, anticarcinogenic, antiatherogenic and antioxidant actions. In this study, we investigated the effects of green tea polyphenols (GTPs) and their principal catechins on the function of P-glycoprotein (P-gp), which is involved in the multidrug resistance phenotype of cancer cells. GTPs (30 microg/ml) inhibit the photolabeling of P-gp by 75% and increase the accumulation of rhodamine-123 (R-123) 3-fold in the multidrug-resistant cell line CH(R)C5, indicating that GTPs interact with P-gp and inhibit its transport activity. Moreover, the modulation of P-gp transport by GTPs was a reversible process. Among the catechins present in GTPs, EGCG, ECG and CG are responsible for inhibiting P-gp. In addition, EGCG potentiates the cytotoxicity of vinblastine (VBL) in CH(R)C5 cells. The inhibitory effect of EGCG on P-gp was also observed in human Caco-2 cells, which form an intestinal epithelial-like monolayer. Our results indicate that, in addition to their anti-cancer properties, GTPs and more particularly EGCG inhibit the binding and efflux of drugs by P-gp. Thus, GTPs or EGCG might be potential agents for modulating the bioavailability of P-gp substrates at the intestine and the multidrug resistance phenotype associated with expression of this transporter in cancer cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11853888     DOI: 10.1016/s0167-4889(01)00175-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  46 in total

Review 1.  Structure and function of efflux pumps that confer resistance to drugs.

Authors:  M Ines Borges-Walmsley; Kenneth S McKeegan; Adrian R Walmsley
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

Review 2.  Targeting tumor ubiquitin-proteasome pathway with polyphenols for chemosensitization.

Authors:  Min Shen; Tak Hang Chan; Q Ping Dou
Journal:  Anticancer Agents Med Chem       Date:  2012-10-01       Impact factor: 2.505

Review 3.  Potential Influence of Centrally Acting Herbal Drugs on Transporters at the Blood-Cerebrospinal Fluid Barrier and Blood-Brain Barrier.

Authors:  Lilian W Kibathi; SoHyun Bae; Scott R Penzak; Parag Kumar
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-12       Impact factor: 2.441

4.  Exposure of LS-180 cells to drugs of diverse physicochemical and therapeutic properties up-regulates P-glycoprotein expression and activity.

Authors:  Alaa H Abuznait; Shawn G Patrick; Amal Kaddoumi
Journal:  J Pharm Pharm Sci       Date:  2011       Impact factor: 2.327

5.  Lack of pharmacokinetic interaction between fluvastatin and green tea in healthy volunteers.

Authors:  Shingen Misaka; Osamu Abe; Hideyuki Sato; Tomoyuki Ono; Yayoi Shikama; Satomi Onoue; Hirooki Yabe; Junko Kimura
Journal:  Eur J Clin Pharmacol       Date:  2018-01-24       Impact factor: 2.953

6.  Mutual interactions between flavonoids and enzymatic and transporter elements responsible for flavonoid disposition via phase II metabolic pathways.

Authors:  Wen Jiang; Ming Hu
Journal:  RSC Adv       Date:  2012-09-21       Impact factor: 3.361

7.  Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.

Authors:  Pornngarm Limtrakul; Wanida Chearwae; Suneet Shukla; Chada Phisalphong; Suresh V Ambudkar
Journal:  Mol Cell Biochem       Date:  2006-09-08       Impact factor: 3.396

Review 8.  Cancer stem cells and cancer therapy.

Authors:  Sara Soltanian; Maryam M Matin
Journal:  Tumour Biol       Date:  2011-02-12

9.  The sensitization of glioma cells to cisplatin and tamoxifen by the use of catechin.

Authors:  Amal Shervington; Vidya Pawar; Sharad Menon; Dipti Thakkar; Rahima Patel
Journal:  Mol Biol Rep       Date:  2008-06-26       Impact factor: 2.316

10.  EGCG inhibits properties of glioma stem-like cells and synergizes with temozolomide through downregulation of P-glycoprotein inhibition.

Authors:  Yong Zhang; Shao-Xiang Wang; Ji-Wei Ma; Hai-Ying Li; Jie-Cheng Ye; Si-Ming Xie; Bin Du; Xue-Yun Zhong
Journal:  J Neurooncol       Date:  2014-08-31       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.